©The Author(s) 2016.
World J Gastroenterol. Jan 21, 2016; 22(3): 1067-1077
Published online Jan 21, 2016. doi: 10.3748/wjg.v22.i3.1067
Published online Jan 21, 2016. doi: 10.3748/wjg.v22.i3.1067
Table 2 Methods of endothelium dysfunction assessment
| Proteins activated by normal and activated endothelium | Cell-based methods |
| Angiopoietin-1 | Circulating angiogenic cells |
| Angiopoietin-2 | Endothelial progenitor cells |
| Asymmetric dimethylarginine (ADMA) | Endothelial microparticles |
| Disintegrin and metalloproteinase with thrombospondin motif-13 (ADAMTS13) | |
| Intercellular adhesion molecule-1 (CAM-1) | |
| Plasminogen-activator inhibitor (PAI-1) | |
| Selectins P and E | |
| Tissue plasminogen activator (t-PA) | |
| Thrombomodulin | |
| Vascular adhesion molecule-1 (VCAM-1) | |
| Vascular endothelial growth factor (VEGF) | |
| von Willebrand factor (vWF) | |
| Non-invasive physical methods | |
| Carotis intima-media thickness (cIMT) | |
| Flow mediated dilatation (FMD) | |
| Pulse arterial tonometry (PAT) | |
| Pulse wave analysis (PWA) | |
| Pulse wave velocity (PWV) | |
| Reactive hyperaemia index (RHI) | |
- Citation: Cibor D, Domagala-Rodacka R, Rodacki T, Jurczyszyn A, Mach T, Owczarek D. Endothelial dysfunction in inflammatory bowel diseases: Pathogenesis, assessment and implications. World J Gastroenterol 2016; 22(3): 1067-1077
- URL: https://www.wjgnet.com/1007-9327/full/v22/i3/1067.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i3.1067